181 related articles for article (PubMed ID: 17474825)
1. Comment on "lithium and clozapine rechallenge: a retrospective case analysis".
Esposito D
J Clin Psychiatry; 2007 Apr; 68(4):635; author reply 635. PubMed ID: 17474825
[No Abstract] [Full Text] [Related]
2. Lithium and clozapine rechallenge: a retrospective case analysis.
Kanaan RA; Kerwin RW
J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
[TBL] [Abstract][Full Text] [Related]
3. Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be Risky.
Boazak M; Goldsmith DR; Cotes RO
Prim Care Companion CNS Disord; 2018 Nov; 20(6):. PubMed ID: 30549484
[No Abstract] [Full Text] [Related]
4. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
5. A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.
Martina AC; Ee JS; Lamberti JS
Schizophr Res; 2019 Aug; 210():308-309. PubMed ID: 31277977
[No Abstract] [Full Text] [Related]
6. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
7. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
8. Lithium and clozapine-induced neutropenia/agranulocytosis.
Blier P; Slater S; Measham T; Koch M; Wiviott G
Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
[TBL] [Abstract][Full Text] [Related]
9. Failure of rechallenge clozapine after agranulocytosis: A case report.
Roméo B; Petillion A; Martelli C; Benyamina A
Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
[No Abstract] [Full Text] [Related]
10. Clozapine-Associated Neutropenia and Agranulocytosis.
Andres E; Mourot-Cottet R
J Clin Psychopharmacol; 2017 Dec; 37(6):749-750. PubMed ID: 29040154
[No Abstract] [Full Text] [Related]
11. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
Silva E; Higgins M; Hammer B; Stephenson P
BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
[TBL] [Abstract][Full Text] [Related]
12. Clozapine, agranulocytosis, and benign ethnic neutropenia.
Rajagopal S
Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
[No Abstract] [Full Text] [Related]
13. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
Simon L; Cazard F
Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
[TBL] [Abstract][Full Text] [Related]
14. Use of lithium in clozapine-induced neutropenia: a case report.
Suraweera C; Hanwella R; de Silva V
BMC Res Notes; 2014 Sep; 7():635. PubMed ID: 25214394
[TBL] [Abstract][Full Text] [Related]
15. [Granulocytopenia while using clozapine: continuing or stopping treatment].
Bogers JP
Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
[TBL] [Abstract][Full Text] [Related]
16. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
Lau KL; Yim PH
East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical pattern of haematological risk with clozapine.
Gillman K
Br J Psychiatry; 2000 Jul; 177():88. PubMed ID: 10945101
[No Abstract] [Full Text] [Related]
18. Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report.
Yamaki N; Hishimoto A; Otsuka I; Sasada T; Boku S; Saito T; Yasuda Y; Yamamori H; Ikeda M; Ikeda M; Sora I; Iwata N; Hashimoto R
Psychiatry Clin Neurosci; 2017 Apr; 71(4):289-290. PubMed ID: 28097743
[No Abstract] [Full Text] [Related]
19. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
Ruiz-Doblado S; Plasencia-García de Diego B; Perea-Pérez R; Jiménez-Gonzalo F
Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914
[No Abstract] [Full Text] [Related]
20. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
